Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Human nocturnal frontal lobe epilepsy: Pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor β-subunit mutations outside the ion channel pore
Other Titles: Human nocturnal frontal lobe epilepsy: Pharmocogenomic profiles of pathogenic nicotinic acetylcholine receptor beta-subunit mutations outside the ion channel pore
Author: Hoda, J.
Gu, W.
Friedli, M.
Phillips, H.
Bertrand, S.
Antonarakis, S.
Goudie, D.
Roberts, R.
Scheffer, I.
Marini, C.
Patel, J.
Berkovic, S.
Mulley, J.
Steinlein, O.
Bertrand, D.
Citation: Molecular Pharmacology, 2008; 74(2):379-391
Publisher: Amer Soc Pharmacology Experimental Therapeutics
Issue Date: 2008
ISSN: 0026-895X
Statement of
Jean-Charles Hoda, Wenli Gu, Marc Friedli, Hilary A. Phillips, Sonia Bertrand, Stylianos E. Antonarakis, David Goudie, Richard Roberts, Ingrid E. Scheffer, Carla Marini, Jayesh Patel, Samuel F. Berkovic, John C. Mulley, Ortrud K. Steinlein, and Daniel Bertrand
Abstract: Certain mutations in specific parts of the neuronal nicotinic acetylcholine receptor (nAChR) subunit genes CHRNA4, CHRNB2, and probably CHRNA2, can cause autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). All but one of the known causative mutations are located in the second transmembrane region (TM2), which serves as the major ion poreforming domain of the receptor. Functional characterization of these ADNFLE mutations has shown that although each mutant exhibits specific properties, they all confer a gain of function with increased sensitivity to acetylcholine. In this work, we characterize the second and third ADNFLE-associated mutations that are external to TM2 but affect different amino acid residues within the third transmembrane region (TM3). The two new CHRNB2 mutations were identified in three families of Turkish Cypriot, Scottish, and English origin. These TM3 mutations elicit the same gain of function pathomechanism as observed for the TM2 mutations with enhanced acetylcholine sensitivity, despite their unusual localization within the gene. Electrophysiological experiments, including single channel measurements, revealed that incorporation of these new mutant subunits does not affect the conductance of the ionic pore but increases the probability of opening. Determination of the sensitivity to nicotine for nAChRs carrying mutations in TM2 and TM3 showed clear differences in the direction and the extent to which the window current for nicotine sensitivity was shifted for individual mutations, indicating differences in pharmacogenomic properties that are not readily correlated with increased ACh affinity.
Keywords: Cell Line; Animals; Xenopus laevis; Humans; Epilepsy, Frontal Lobe; Sleep Disorders; Ion Channels; Receptors, Nicotinic; Protein Subunits; Anticonvulsants; Patch-Clamp Techniques; Amino Acid Substitution; Pharmacogenetics; Mutation; Adolescent; Adult; Female; Male
RMID: 0020081634
DOI: 10.1124/mol.107.044545
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.